InxMed Co grabs $50m Series B
InxMed Co., Ltd, a clinical-stage biotechnology company, has secured $50 million in Series B financing.
InxMed Co., Ltd, a clinical-stage biotechnology company, has secured $50 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination